Dan and Mike examine the loss of PDP commissions and what it means for agents, clients, and carrier economics. They discuss differences between new and renewal compensation, the need for clear carrier comparisons, and pressures linked to drug benefits and payment changes. The conversation places commission disruption within wider questions about regulation, affordability, and sustainable insurance distribution.
In this episode
- PDP commission changes
- Renewal compensation
- Prescription plan economics
- Carrier comparisons
- Distribution sustainability
Show notes
In this episode we discuss Wellcare PDP plans going non commissionable on renewals and new enrollments. We discuss why Wellcare and others may be making those hard decisions and the broader impact on the distribution environment. We also talk about agents that dogmatically only sell supplements or Advantage plans and how that mindset may be shifting.